[EN] COMPOUNDS WITH ACTIVITY ON MUSCARINIC RECEPTORS<br/>[FR] COMPOSES POSSEDANT UNE ACTIVITE SUR LES RECEPTEURS MUSCARINIQUES
申请人:ACADIA PHARM INC
公开号:WO2001005763A2
公开(公告)日:2001-01-25
Compounds and methods are provided for the alleviation or treatment of diseases or conditions in which modification of muscarinic m1 receptor activity has a beneficial effect. In the method, a therapeutically effective amount of a selective muscarinic m1 agonist compound is administered to a patient in need of such treatment.